The Anthem Biosciences Limited IPO is opening on 14 July 2025 and will close on 16 July 2025. This is a mainboard IPO raising ₹3395 crore from a complete Offer for Sale (OFS) of 5.96 crore equity shares.
The Anthem Biosciences IPO allotment date will be decided on Thursday, 17 July 2025. Anthem Biosciences shares will be tentatively listed on NSE and BSE on Monday, 21 July 2025.
The Anthem Biosciences price band has been between ₹540 and ₹570 per share. The minimum lot size decided for the IPO is 26 shares, making the minimum investment as ₹14040 for retail investors. The sNII needs to subscribe to at least 14 lots, amounting to a minimum investment of ₹207480, and the bNII needs to subscribe to 68 lots, minimum investment amounting to ₹1007760.
Here Are the Quick Steps to Apply for the Anthem Biosciences IPO with the Best IPO App!
Anthem Biosciences NSE BSE IPO Details
Detail | Information |
IPO Opening Date | July 14, 2025 |
IPO Closing Date | July 16, 2025 |
Tentative IPO Listing Date | July 21, 2025 |
Face Value | ₹2 per share |
Price Range | ₹540 to ₹570 per share |
Lot Size | 26 shares |
Total Issue Size | 59561404 Shares (₹3395 Cr.) |
OFS | 59561404 Shares (₹3395 Cr.) |
IPO Segment | Book Building Issue |
Listing At | NSE & BSE |
Shareholding Pre-Issue | 559077100 shares |
Shareholding post-issue | 559077100 shares |
Anthem Biosciences Limited | Company Overview
Anthem Biosciences Limited was incorporated in 2006 as a Contract Research, Development, and Manufacturing Organization (CRDMO). It offers innovation and tech-first approach for developing pharma products.
It offers its services to a wide number of biotech firms, pharmaceutical companies, both domestically and globally. The firm specializes in manufacturing Fermentation-based APIs, which include –
- Enzymes
- Peptides
- Nutrition actives
- Vitamin analogues
- Biosimilars
- Others
As of 30 September 2024, the firm has 196 projects out of which 170 were discovery projects. The company has 550 customers across 44 countries by this date.
Anthem Biosciences Limited IPO | Key Details
- Anthem Biosciences IPO Opening Date: July 14, 2025,
- Anthem Biosciences IPO Closing Date: July 16, 2025.
- Allotment Date: July 17, 2025
- Price Band: ₹540 to ₹570 per share
- Lot Size: 26 shares
- Refunds Initiated: July 18, 2025
- Shares Credited to Demat: July 18, 2025
- Listing Date: July 21, 2025
Anthem Biosciences Ltd: Financial Overview
Anthem Biosciences Limited’s profits surged by 22%, from a 30% jump in revenue during FY25.
Here is a snapshot of the financials –
Amounts in ₹ Crore
Financial Information | 31-Mar-25 | 31-Mar-24 | Change | Change (%) |
Assets | 2,807.58 | 2,398.11 | 409.47 | 17.07469632 |
Revenue | 1,930.29 | 1,483.07 | 447.22 | 30.15501628 |
Profit After Tax | 451.26 | 367.31 | 83.95 | 22.85535379 |
EBITDA | 683.78 | 519.96 | 163.82 | 31.50626971 |
Net Worth | 2,409.86 | 1,924.66 | 485.2 | 25.20964742 |
Reserves and Surplus | 2,298.05 | 1,815.39 | 482.66 | 26.58712453 |
Total Borrowing | 108.95 | 232.53 | -123.58 | -53.1458306 |
Anthem Biosciences Ltd IPO | FAQs
Anthem Biosciences Ltd is engaged in the manufacturing of pharma products as a CRDMO.
The tentative IPO listing date of Anthem Biosciences has been fixed as Monday, 21 July 2025.
The bidding date for the Anthem Biosciences IPO is July 14, 2025, and it will continue until July 16, 2025.
The minimum IPO lot size for Anthem Biosciences is 26 shares.
The IPO allotment is expected to be finalized on Thursday, July 17, 2025.
The IPO face value is set at ₹2 per share.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.